Dr. Matthew Dietz
Claim this profilePrimary Children's Hospital
Expert in Uterine Tumors
Expert in Neuroblastoma
33 reported clinical trials
64 drugs studied
Area of expertise
1Uterine Tumors
Global LeaderStage I
Stage IV
Stage II
2Neuroblastoma
Global LeaderMYC positive
Stage IV
MYC negative
Affiliated Hospitals
Clinical Trials Matthew Dietz is currently running
Chemotherapy
for Rhabdomyosarcoma
This trial is testing four different chemotherapy schedules for patients with a specific type of advanced cancer. The goal is to find the best way to treat the disease by comparing different timing and combinations of chemotherapy treatments.
Recruiting1 award Phase 2
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
More about Matthew Dietz
Clinical Trial Related7 years of experience running clinical trials · Led 33 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Matthew Dietz has experience with
- Cyclophosphamide
- Carboplatin
- Etoposide
- Cisplatin
- Larotrectinib
- Vincristine
Breakdown of trials Matthew Dietz has run
Uterine Tumors
Neuroblastoma
Rhabdomyosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Dietz specialize in?
Matthew Dietz focuses on Uterine Tumors and Neuroblastoma. In particular, much of their work with Uterine Tumors has involved Stage I patients, or patients who are Stage IV.
Is Matthew Dietz currently recruiting for clinical trials?
Yes, Matthew Dietz is currently recruiting for 10 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Matthew Dietz has studied deeply?
Yes, Matthew Dietz has studied treatments such as Cyclophosphamide, Carboplatin, Etoposide.
What is the best way to schedule an appointment with Matthew Dietz?
Apply for one of the trials that Matthew Dietz is conducting.
What is the office address of Matthew Dietz?
The office of Matthew Dietz is located at: Primary Children's Hospital, Salt Lake City, Utah 84113 United States. This is the address for their practice at the Primary Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.